NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,736,600 | -50.9% | 1,900,000 | -50.0% | 0.00% | – |
| Q1 2023 | $3,534,000 | +105.0% | 3,800,000 | +100.0% | 0.00% | – |
| Q4 2022 | $1,724,250 | -3.1% | 1,900,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,779,000 | +1.5% | 1,900,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,752,000 | -13.9% | 1,900,000 | 0.0% | 0.00% | – |
| Q1 2022 | $2,035,000 | -2.9% | 1,900,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,096,000 | -18.0% | 1,900,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,557,000 | -22.1% | 1,900,000 | 0.0% | 0.00% | – |
| Q2 2021 | $3,282,000 | +12.4% | 1,900,000 | 0.0% | 0.00% | – |
| Q1 2021 | $2,920,000 | -44.5% | 1,900,000 | -34.5% | 0.00% | – |
| Q4 2020 | $5,258,000 | +18.1% | 2,900,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,453,000 | +13.2% | 2,900,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,934,000 | – | 2,900,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
| Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
| DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
| Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
| ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
| Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
| Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
| PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |